Aramark (ARMK) is overvalued and Cintas Corp (CTAS) is overvalued.
Both trade above our estimate of their intrinsic value. ARMK is the closer of the two: -73%, against -112% for CTAS.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.8% (average of 2 methods) values the shares at $32.78; the price of $56.59 is 73% above that value, and 77% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
Discounting its cash flows at 9.6% (average of 3 methods) values the shares at $93.81; the price of $198.80 is 112% above that value, and 74% of that value comes from beyond year five.
Leak Score 67/100 on 10 of 12 signals
| Metric | ARMK | CTAS |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $56.59 | $198.80 |
| Intrinsic value | $32.78 | $93.81 |
| Margin of safety | -73% | -112% |
| Leak Score | 14/100 (3/12) | 67/100 (10/12) |
| Market cap | $14.9B | $79.7B |
| Revenue growth, 5 years | 7.6% | 9.6% |
| Operating margin | 4.4% | 23.3% |
| Net margin | 1.9% | 17.7% |
| Return on equity | 11.8% | 40.6% |
| Debt to equity | 1.91 | 0.53 |
| P/E | 39.5x | 40.5x |
| Forward P/E | 20.1x | 32.4x |
| P/B | 4.4x | 15.5x |
| Dividend yield | 0.9% | 0.9% |